跳至主要内容
临床试验/NCT04505111
NCT04505111撤回不适用

Prehabilitation Plus Enhanced Recovery After Surgery Versus Enhanced Recovery After Surgery in Gynecological Surgery

Instituto Brasileiro de Controle do Cancer2 个研究点 分布在 1 个国家开始时间: 2020年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Postoperative recovery time

研究概览

简要总结

Prospective, interventionist, controlled and randomized study to test the effectiveness of multimodal prehabilitation protocol in patients who will undergo gynecological surgery.

详细描述

Prospective, interventionist and randomized controlled trial in a 1: 1 ratio, open to the multidisciplinary team but blind to surgeons and anaesthesiologists. The aim is to test the effectiveness of a multimodal prehabilitation protocol in patients with diagnosed or suspicious gynaecological cancer, who will undergo gynaecological surgery.

The multidisciplinary prehabilitation program will be applied to the intervention group. For the group participating in the prehabilitation and for the control group, the protocol and specific recommendations for gynecological cancer defined by the Enhanced Recovery After Surgery (ERAS®) guidelines will be applied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

Single-Blind (surgeons and anesthesiologists)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who sign the Informed Consent Form, indicating that they understand the study procedures and their purpose;
  • Women aged between 18 and 80 years old;
  • Gynecological surgery performed by laparotomy;
  • Patients with Eastern Cooperative Oncology Group Performance Status of at least 2 (ECOG ≤2);
  • Preoperative schedule that allows prehabilitation intervention for 2 to 3 weeks

排除标准

  • Patients under 18 or older than 80 years old;
  • Significant comorbidities, such as: neurological or musculoskeletal disorder, heart disease and / or respiratory failure that prohibit physical exercise;
  • Limitation of locomotion preventing the patient to perform physical exercises;
  • Cognitive deterioration or patients with psychiatric disorder that prevents adherence to the program;
  • Emergency or urgency surgeries;
  • Surgeries by minimally invasive approach (laparoscopy or robotics);
  • Vulvectomy or soft tissue surgery without abdominal approach;
  • Minor gynaecological surgeries such as conizations;
  • Surgeries performed together with other specialties, in which the gynecology team is not primarily responsible for postoperative care;
  • Non-adherence of the patient in the intervention group to the preoperative prehabilitation program.
  • If surgery is performed 21 days after the last day of the prehabilitation program, for any reason

结局指标

主要结局

Postoperative recovery time

时间窗: Up to 30 postoperative days

Postoperative day patient is ready for discharge, defined as the day the patient has the ability to walk alone, take care of herself, and ingest at least 75% of the daily caloric needs

次要结局

  • Change in muscle strength(Baseline and postoperatively at 30 and 60 days)
  • Health-related Quality of Life(At Baseline, then at 30 and 60 days postoperatively)
  • Complications(Up to 30 postoperative days)
  • Change in body mass(Baseline and postoperatively at 30 and 60 days)
  • Readmissions(Up to 30 postoperative days)
  • Changes in anxiety and depression from baseline(Baseline and postoperatively at 30 and 60 days)
  • Changes in functional capacity from baseline(Baseline and postoperatively at 30 and 60 days)
  • Compliance to the ERAS® program guidelines(Through study completion, an average of 1 year)
  • Intensive Care Unit admission rates(Up to 30 postoperative days)
  • Hospital stay(Up to 30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

André Lopes

MD

Instituto Brasileiro de Controle do Cancer

研究点 (2)

Loading locations...

相似试验